世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

メソセラピーの世界市場調査報告書 2022年

メソセラピーの世界市場調査報告書 2022年


Global Mesotherapy Market Research Report 2022

2021年の世界のメソセラピー市場規模は6億8969万米ドルで、2028年には12億1589万米ドルに達し、2022年から2028年の間にCAGR7.94%で成長すると予測されています。 本レポートでは、世界レベル、地域レベル、企業... もっと見る

　

　

出版社 出版年月 電子版価格 納期 言語
QYResearch
QYリサーチ 		2022年6月15日 US$2,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		5-7営業日 英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

2021年の世界のメソセラピー市場規模は6億8969万米ドルで、2028年には12億1589万米ドルに達し、2022年から2028年の間にCAGR7.94%で成長すると予測されています。
本レポートでは、世界レベル、地域レベル、企業レベルでのメソセラピーの数量と価値に焦点を当てています。グローバルな視点から、過去のデータと将来の見通しを分析することで、メソセラピーの全体的な市場規模を表現しています。地域的には、このレポートはいくつかの主要地域に焦点を当てています。北米、欧州、中国、日本、韓国などです。

メソセラピーの世界市場セグメント分析
この調査レポートは、地域（国）別、企業別、タイプ別、用途別の具体的なセグメントを含んでいます。この調査では、2017年から2028年までの歴史的期間と予測期間における売上高と収益に関する情報を提供しています。セグメントを理解することは、市場成長を助ける様々な要因の重要性を特定するのに役立ちます。

世界のメソセラピー市場セグメント分析
この調査レポートは、地域（国）別、メーカー別、タイプ別、用途別の具体的なセグメントを含んでいます。各タイプは、2017年から2028年の予測期間中の生産に関する情報を提供します。 アプリケーション別セグメントはまた、2017年から2028年の予測期間中の消費量を提供します。セグメントを理解することは、市場の成長を助けるさまざまな要因の重要性を特定するのに役立ちます。

企業別
フィロルガ
テオキサン
アラガン
ベネブスキンケア
テバファーム
チャメディテック
ドングクライフサイエンス
ヒュオン
ブルマージュフレダ
上海奇生
イヴ・チャーム
パベイ
サンマックスバイオテック
イメック

種類別セグメント
基礎メソセラピー
複合メソセラピー
マイクロニードル
その他

用途別セグメント
病院
クリニック
美容院
その他

地域別消費量
北アメリカ
米国
カナダ
メキシコ

アジア・パシフィック
中国
日本
韓国

欧州
ドイツ
フランス
英国
イタリア
スペイン
その他の地域

南米
ブラジル
南米のその他


ページTOPに戻る


目次

1 MESOTHERAPY MARKET OVERVIEW 1
1.1 PRODUCT OVERVIEW AND SCOPE OF MESOTHERAPY 1
1.2 MESOTHERAPY SEGMENT BY TYPE 1
1.2.1 GLOBAL MESOTHERAPY SALES GROWTH RATE COMPARISON BY TYPE (2022-2028) 1
1.2.2 BASIC MESOTHERAPY 2
1.2.3 COMPOUND MESOTHERAPY 2
1.2.4 MICRO NEEDLE 3
1.2.5 OTHER 3
1.3 MESOTHERAPY SEGMENT BY APPLICATION 3
1.3.1 GLOBAL MESOTHERAPY SALES COMPARISON BY APPLICATION (2022-2028) 3
1.3.2 HOSPITAL 4
1.3.3 CLINIC 5
1.3.4 BEAUTY AGENCY 6
1.3.5 OTHER 6
1.4 GLOBAL MESOTHERAPY MARKET SIZE ESTIMATES AND FORECASTS 6
1.4.1 GLOBAL MESOTHERAPY REVENUE 2017-2028 6
1.4.2 GLOBAL MESOTHERAPY SALES 2017-2028 8
1.4.3 MESOTHERAPY MARKET SIZE BY REGION: 2017 VERSUS 2021 VERSUS 2028 9
2 MESOTHERAPY MARKET COMPETITION BY MANUFACTURERS 10
2.1 GLOBAL MESOTHERAPY SALES MARKET SHARE BY MANUFACTURERS (2017-2022) 10
2.2 GLOBAL MESOTHERAPY REVENUE MARKET SHARE BY MANUFACTURERS (2017-2022) 13
2.3 GLOBAL MESOTHERAPY AVERAGE PRICE BY MANUFACTURERS (2017-2022) 15
2.4 MANUFACTURERS MESOTHERAPY MANUFACTURING SITES, AREA SERVED 15
2.5 MESOTHERAPY MARKET COMPETITIVE SITUATION AND TRENDS 16
2.5.1 MESOTHERAPY MARKET CONCENTRATION RATE 16
2.5.2 THE GLOBAL 5 AND 10 LARGEST MESOTHERAPY PLAYERS MARKET SHARE BY REVENUE 17
2.5.3 GLOBAL MESOTHERAPY MARKET SHARE BY COMPANY TYPE (TIER 1, TIER 2, AND TIER 3) 17
3 MESOTHERAPY RETROSPECTIVE MARKET SCENARIO BY REGION 19
3.1 GLOBAL MESOTHERAPY RETROSPECTIVE MARKET SCENARIO IN SALES BY REGION: 2017-2022 19
3.2 GLOBAL MESOTHERAPY RETROSPECTIVE MARKET SCENARIO IN REVENUE BY REGION: 2017-2022 19
3.3 NORTH AMERICA MESOTHERAPY MARKET FACTS & FIGURES BY COUNTRY 20
3.3.1 NORTH AMERICA MESOTHERAPY SALES BY COUNTRY 20
3.3.2 NORTH AMERICA MESOTHERAPY REVENUE BY COUNTRY 21
3.3.3 U.S. 22
3.3.4 CANADA 23
3.3.5 MEXICO 24
3.4 EUROPE MESOTHERAPY MARKET FACTS & FIGURES BY COUNTRY 24
3.4.1 EUROPE MESOTHERAPY SALES BY COUNTRY 24
3.4.2 EUROPE MESOTHERAPY REVENUE BY COUNTRY 25
3.4.3 GERMANY 26
3.4.4 FRANCE 27
3.4.5 U.K. 28
3.4.6 ITALY 29
3.4.7 SPAIN 30
3.5 ASIA PACIFIC MESOTHERAPY MARKET FACTS & FIGURES BY REGION 30
3.5.1 ASIA PACIFIC MESOTHERAPY SALES BY REGION 30
3.5.2 ASIA PACIFIC MESOTHERAPY REVENUE BY REGION 31
3.5.3 CHINA 32
3.5.4 JAPAN 33
3.5.5 SOUTH KOREA 34
3.6 SOUTH AMERICA MESOTHERAPY MARKET FACTS & FIGURES BY COUNTRY 34
3.6.1 SOUTH AMERICA MESOTHERAPY SALES BY COUNTRY 34
3.6.2 SOUTH AMERICA MESOTHERAPY REVENUE BY COUNTRY 35
3.6.3 BRAZIL 36
3.7 MIDDLE EAST AND AFRICA MESOTHERAPY MARKET FACTS & FIGURES BY COUNTRY 36
3.7.1 MIDDLE EAST AND AFRICA MESOTHERAPY SALES BY COUNTRY 36
3.7.2 MIDDLE EAST AND AFRICA MESOTHERAPY REVENUE BY COUNTRY 37
3.7.3 MIDDLE EAST 38
3.7.4 AFRICA 38
4 MESOTHERAPY HISTORIC MARKET ANALYSIS BY TYPE 39
4.1 GLOBAL MESOTHERAPY SALES MARKET SHARE BY TYPE (2017-2022) 39
4.2 GLOBAL MESOTHERAPY REVENUE MARKET SHARE BY TYPE (2017-2022) 40
4.3 GLOBAL MESOTHERAPY PRICE BY TYPE (2017-2022) 41
5 MESOTHERAPY HISTORIC MARKET ANALYSIS BY APPLICATION 42
5.1 GLOBAL MESOTHERAPY SALES MARKET SHARE BY APPLICATION (2017-2022) 42
5.2 GLOBAL MESOTHERAPY REVENUE MARKET SHARE BY APPLICATION (2017-2022) 42
5.3 GLOBAL MESOTHERAPY PRICE BY APPLICATION (2017-2022) 43
6 KEY COMPANIES PROFILED 44
6.1 FILORGA 44
6.1.1 FILORGA CORPORATION INFORMATION 44
6.1.2 FILORGA DESCRIPTION AND BUSINESS OVERVIEW 44
6.1.3 FILORGA MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022) 45
6.1.4 FILORGA MESOTHERAPY PRODUCT PORTFOLIO 45
6.1.5 FILORGA RECENT DEVELOPMENTS/UPDATES 45
6.2 TEOXANE 46
6.2.1 TEOXANE CORPORATION INFORMATION 46
6.2.2 TEOXANE DESCRIPTION AND BUSINESS OVERVIEW 46
6.2.3 TEOXANE MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022) 46
6.2.4 TEOXANE MESOTHERAPY PRODUCT PORTFOLIO 47
6.3 ALLERGAN 47
6.3.1 ALLERGAN CORPORATION INFORMATION 47
6.3.2 ALLERGAN DESCRIPTION AND BUSINESS OVERVIEW 48
6.3.3 ALLERGAN MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022) 48
6.3.4 ALLERGAN MESOTHERAPY PRODUCT PORTFOLIO 48
6.4 BENEV SKINCARE 49
6.4.1 BENEV SKINCARE CORPORATION INFORMATION 49
6.4.2 BENEV SKINCARE DESCRIPTION AND BUSINESS OVERVIEW 49
6.4.3 BENEV SKINCARE MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022) 49
6.4.4 BENEV SKINCARE MESOTHERAPY PRODUCT PORTFOLIO 50
6.5 TEVAPHARM 51
6.5.1 TEVAPHARM CORPORATION INFORMATION 51
6.5.2 TEVAPHARM DESCRIPTION AND BUSINESS OVERVIEW 51
6.5.3 TEVAPHARM MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022) 52
6.5.4 TEVAPHARM MESOTHERAPY PRODUCT PORTFOLIO 52
6.6 CHAMEDITHEC 53
6.6.1 CHAMEDITHEC CORPORATION INFORMATION 53
6.6.2 CHAMEDITHEC DESCRIPTION AND BUSINESS OVERVIEW 54
6.6.3 CHAMEDITHEC MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022) 54
6.6.4 CHAMEDITHEC MESOTHERAPY PRODUCT PORTFOLIO 55
6.7 DONG KOOK LIFESCIENCE 55
6.7.1 DONG KOOK LIFESCIENCE CORPORATION INFORMATION 55
6.7.2 DONG KOOK LIFESCIENCE DESCRIPTION AND BUSINESS OVERVIEW 56
6.7.3 DONG KOOK LIFESCIENCE MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022) 56
6.7.4 DONG KOOK LIFESCIENCE MESOTHERAPY PRODUCT PORTFOLIO 57
6.8 HUONS 57
6.8.1 HUONS CORPORATION INFORMATION 57
6.8.2 HUONS DESCRIPTION AND BUSINESS OVERVIEW 58
6.8.3 HUONS MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022) 58
6.8.4 HUONS MESOTHERAPY PRODUCT PORTFOLIO 59
6.9 BLOOMAGEFREDA 59
6.9.1 BLOOMAGEFREDA CORPORATION INFORMATION 59
6.9.2 BLOOMAGEFREDA DESCRIPTION AND BUSINESS OVERVIEW 60
6.9.3 BLOOMAGEFREDA MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022) 60
6.9.4 BLOOMAGEFREDA MESOTHERAPY PRODUCT PORTFOLIO 60
6.10 SHANGHAI QISHENG 62
6.10.1 SHANGHAI QISHENG CORPORATION INFORMATION 62
6.10.2 SHANGHAI QISHENG DESCRIPTION AND BUSINESS OVERVIEW 62
6.10.3 SHANGHAI QISHENG MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022) 63
6.10.4 SHANGHAI QISHENG MESOTHERAPY PRODUCT PORTFOLIO 63
6.11 EVE CHARM 63
6.11.1 EVE CHARM CORPORATION INFORMATION 63
6.11.2 EVE CHARM DESCRIPTION AND BUSINESS OVERVIEW 64
6.11.3 EVE CHARM MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022) 64
6.11.4 EVE CHARM MESOTHERAPY PRODUCT PORTFOLIO 65
6.12 PAVAY 65
6.12.1 PAVAY CORPORATION INFORMATION 65
6.12.2 PAVAY DESCRIPTION AND BUSINESS OVERVIEW 66
6.12.3 PAVAY MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022) 66
6.12.4 PAVAY MESOTHERAPY PRODUCT PORTFOLIO 66
6.13 SUNMAX BIOTECH 67
6.13.1 SUNMAX BIOTECH CORPORATION INFORMATION 67
6.13.2 SUNMAX BIOTECH DESCRIPTION AND BUSINESS OVERVIEW 68
6.13.3 SUNMAX BIOTECH MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022) 68
6.13.4 SUNMAX BIOTECH MESOTHERAPY PRODUCT PORTFOLIO 68
6.14 IMEIK 69
6.14.1 IMEIK CORPORATION INFORMATION 69
6.14.2 IMEIK DESCRIPTION AND BUSINESS OVERVIEW 69
6.14.3 IMEIK MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022) 70
6.14.4 IMEIK MESOTHERAPY PRODUCT PORTFOLIO 70
7 MESOTHERAPY MANUFACTURING COST ANALYSIS 71
7.1 MESOTHERAPY KEY RAW MATERIALS ANALYSIS 71
7.1.1 KEY RAW MATERIALS 71
7.1.2 KEY SUPPLIERS OF RAW MATERIALS 71
7.2 PROPORTION OF MANUFACTURING COST STRUCTURE 72
7.3 MANUFACTURING PROCESS ANALYSIS OF MESOTHERAPY 73
7.4 MESOTHERAPY INDUSTRIAL CHAIN ANALYSIS 74
8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS 75
8.1 MARKETING CHANNEL 75
8.2 MESOTHERAPY DISTRIBUTORS LIST 76
8.3 MESOTHERAPY CUSTOMERS ANALYSIS 77
9 MESOTHERAPY MARKET DYNAMICS 78
9.1 MESOTHERAPY INDUSTRY TRENDS 78
9.2 MESOTHERAPY MARKET DRIVERS 78
9.3 MESOTHERAPY MARKET CHALLENGES 78
9.4 MESOTHERAPY MARKET RESTRAINTS 79
10 GLOBAL MARKET FORECAST 80
10.1 MESOTHERAPY MARKET ESTIMATES AND PROJECTIONS BY TYPE 80
10.1.1 GLOBAL FORECASTED SALES OF MESOTHERAPY BY TYPE (2023-2028) 80
10.1.2 GLOBAL FORECASTED REVENUE OF MESOTHERAPY BY TYPE (2023-2028) 80
10.2 MESOTHERAPY MARKET ESTIMATES AND PROJECTIONS BY APPLICATION 81
10.2.1 GLOBAL FORECASTED SALES OF MESOTHERAPY BY APPLICATION (2023-2028) 81
10.2.2 GLOBAL FORECASTED REVENUE OF MESOTHERAPY BY APPLICATION (2023-2028) 81
10.3 MESOTHERAPY MARKET ESTIMATES AND PROJECTIONS BY REGION 82
10.3.1 GLOBAL FORECASTED SALES OF MESOTHERAPY BY REGION (2023-2028) 82
10.3.2 GLOBAL FORECASTED REVENUE OF MESOTHERAPY BY REGION (2023-2028) 83
11 RESEARCH FINDINGS AND CONCLUSION 84
12 METHODOLOGY AND DATA SOURCE 85
12.1 METHODOLOGY/RESEARCH APPROACH 85
12.1.1 RESEARCH PROGRAMS/DESIGN 85
12.1.2 MARKET SIZE ESTIMATION 86
12.1.3 MARKET BREAKDOWN AND DATA TRIANGULATION 87
12.2 DATA SOURCE 88
12.2.1 SECONDARY SOURCES 88
12.2.2 PRIMARY SOURCES 89
12.3 AUTHOR LIST 92
12.4 DISCLAIMER 92

　

ページTOPに戻る


　

Summary

In 2021, the global Mesotherapy market size was US$ 689.69 million and it will reach US$ 1,215.89 million in 2028, growing at CAGR of 7.94% between 2022 and 2028.
This report focuses on Mesotherapy volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Mesotherapy market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Japan, South Korea, etc.

Global Mesotherapy Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Global Mesotherapy Market: Segment Analysis
The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2017 to 2028. by Application segment also provides consumption during the forecast period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

By Company
Filorga
Teoxane
Allergan
Benev Skincare
Tevapharm
CHAMEDITHEC
Dong Kook Lifescience
Huons
Bloomagefreda
Shanghai Qisheng
EVE CHARM
Pavay
Sunmax Biotech
Imeik

Segment by Type
Basic Mesotherapy
Compound Mesotherapy
Micro Needle
Other

Segment by Application
Hospital
Clinic
Beauty Agency
Other

Consumption by Region
North America
U.S.
Canada
Mexico

Asia-Pacific
China
Japan
South Korea

Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe

South America
Brazil
Rest of South America



ページTOPに戻る


Table of Contents

1 MESOTHERAPY MARKET OVERVIEW 1
1.1 PRODUCT OVERVIEW AND SCOPE OF MESOTHERAPY 1
1.2 MESOTHERAPY SEGMENT BY TYPE 1
1.2.1 GLOBAL MESOTHERAPY SALES GROWTH RATE COMPARISON BY TYPE (2022-2028) 1
1.2.2 BASIC MESOTHERAPY 2
1.2.3 COMPOUND MESOTHERAPY 2
1.2.4 MICRO NEEDLE 3
1.2.5 OTHER 3
1.3 MESOTHERAPY SEGMENT BY APPLICATION 3
1.3.1 GLOBAL MESOTHERAPY SALES COMPARISON BY APPLICATION (2022-2028) 3
1.3.2 HOSPITAL 4
1.3.3 CLINIC 5
1.3.4 BEAUTY AGENCY 6
1.3.5 OTHER 6
1.4 GLOBAL MESOTHERAPY MARKET SIZE ESTIMATES AND FORECASTS 6
1.4.1 GLOBAL MESOTHERAPY REVENUE 2017-2028 6
1.4.2 GLOBAL MESOTHERAPY SALES 2017-2028 8
1.4.3 MESOTHERAPY MARKET SIZE BY REGION: 2017 VERSUS 2021 VERSUS 2028 9
2 MESOTHERAPY MARKET COMPETITION BY MANUFACTURERS 10
2.1 GLOBAL MESOTHERAPY SALES MARKET SHARE BY MANUFACTURERS (2017-2022) 10
2.2 GLOBAL MESOTHERAPY REVENUE MARKET SHARE BY MANUFACTURERS (2017-2022) 13
2.3 GLOBAL MESOTHERAPY AVERAGE PRICE BY MANUFACTURERS (2017-2022) 15
2.4 MANUFACTURERS MESOTHERAPY MANUFACTURING SITES, AREA SERVED 15
2.5 MESOTHERAPY MARKET COMPETITIVE SITUATION AND TRENDS 16
2.5.1 MESOTHERAPY MARKET CONCENTRATION RATE 16
2.5.2 THE GLOBAL 5 AND 10 LARGEST MESOTHERAPY PLAYERS MARKET SHARE BY REVENUE 17
2.5.3 GLOBAL MESOTHERAPY MARKET SHARE BY COMPANY TYPE (TIER 1, TIER 2, AND TIER 3) 17
3 MESOTHERAPY RETROSPECTIVE MARKET SCENARIO BY REGION 19
3.1 GLOBAL MESOTHERAPY RETROSPECTIVE MARKET SCENARIO IN SALES BY REGION: 2017-2022 19
3.2 GLOBAL MESOTHERAPY RETROSPECTIVE MARKET SCENARIO IN REVENUE BY REGION: 2017-2022 19
3.3 NORTH AMERICA MESOTHERAPY MARKET FACTS & FIGURES BY COUNTRY 20
3.3.1 NORTH AMERICA MESOTHERAPY SALES BY COUNTRY 20
3.3.2 NORTH AMERICA MESOTHERAPY REVENUE BY COUNTRY 21
3.3.3 U.S. 22
3.3.4 CANADA 23
3.3.5 MEXICO 24
3.4 EUROPE MESOTHERAPY MARKET FACTS & FIGURES BY COUNTRY 24
3.4.1 EUROPE MESOTHERAPY SALES BY COUNTRY 24
3.4.2 EUROPE MESOTHERAPY REVENUE BY COUNTRY 25
3.4.3 GERMANY 26
3.4.4 FRANCE 27
3.4.5 U.K. 28
3.4.6 ITALY 29
3.4.7 SPAIN 30
3.5 ASIA PACIFIC MESOTHERAPY MARKET FACTS & FIGURES BY REGION 30
3.5.1 ASIA PACIFIC MESOTHERAPY SALES BY REGION 30
3.5.2 ASIA PACIFIC MESOTHERAPY REVENUE BY REGION 31
3.5.3 CHINA 32
3.5.4 JAPAN 33
3.5.5 SOUTH KOREA 34
3.6 SOUTH AMERICA MESOTHERAPY MARKET FACTS & FIGURES BY COUNTRY 34
3.6.1 SOUTH AMERICA MESOTHERAPY SALES BY COUNTRY 34
3.6.2 SOUTH AMERICA MESOTHERAPY REVENUE BY COUNTRY 35
3.6.3 BRAZIL 36
3.7 MIDDLE EAST AND AFRICA MESOTHERAPY MARKET FACTS & FIGURES BY COUNTRY 36
3.7.1 MIDDLE EAST AND AFRICA MESOTHERAPY SALES BY COUNTRY 36
3.7.2 MIDDLE EAST AND AFRICA MESOTHERAPY REVENUE BY COUNTRY 37
3.7.3 MIDDLE EAST 38
3.7.4 AFRICA 38
4 MESOTHERAPY HISTORIC MARKET ANALYSIS BY TYPE 39
4.1 GLOBAL MESOTHERAPY SALES MARKET SHARE BY TYPE (2017-2022) 39
4.2 GLOBAL MESOTHERAPY REVENUE MARKET SHARE BY TYPE (2017-2022) 40
4.3 GLOBAL MESOTHERAPY PRICE BY TYPE (2017-2022) 41
5 MESOTHERAPY HISTORIC MARKET ANALYSIS BY APPLICATION 42
5.1 GLOBAL MESOTHERAPY SALES MARKET SHARE BY APPLICATION (2017-2022) 42
5.2 GLOBAL MESOTHERAPY REVENUE MARKET SHARE BY APPLICATION (2017-2022) 42
5.3 GLOBAL MESOTHERAPY PRICE BY APPLICATION (2017-2022) 43
6 KEY COMPANIES PROFILED 44
6.1 FILORGA 44
6.1.1 FILORGA CORPORATION INFORMATION 44
6.1.2 FILORGA DESCRIPTION AND BUSINESS OVERVIEW 44
6.1.3 FILORGA MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022) 45
6.1.4 FILORGA MESOTHERAPY PRODUCT PORTFOLIO 45
6.1.5 FILORGA RECENT DEVELOPMENTS/UPDATES 45
6.2 TEOXANE 46
6.2.1 TEOXANE CORPORATION INFORMATION 46
6.2.2 TEOXANE DESCRIPTION AND BUSINESS OVERVIEW 46
6.2.3 TEOXANE MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022) 46
6.2.4 TEOXANE MESOTHERAPY PRODUCT PORTFOLIO 47
6.3 ALLERGAN 47
6.3.1 ALLERGAN CORPORATION INFORMATION 47
6.3.2 ALLERGAN DESCRIPTION AND BUSINESS OVERVIEW 48
6.3.3 ALLERGAN MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022) 48
6.3.4 ALLERGAN MESOTHERAPY PRODUCT PORTFOLIO 48
6.4 BENEV SKINCARE 49
6.4.1 BENEV SKINCARE CORPORATION INFORMATION 49
6.4.2 BENEV SKINCARE DESCRIPTION AND BUSINESS OVERVIEW 49
6.4.3 BENEV SKINCARE MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022) 49
6.4.4 BENEV SKINCARE MESOTHERAPY PRODUCT PORTFOLIO 50
6.5 TEVAPHARM 51
6.5.1 TEVAPHARM CORPORATION INFORMATION 51
6.5.2 TEVAPHARM DESCRIPTION AND BUSINESS OVERVIEW 51
6.5.3 TEVAPHARM MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022) 52
6.5.4 TEVAPHARM MESOTHERAPY PRODUCT PORTFOLIO 52
6.6 CHAMEDITHEC 53
6.6.1 CHAMEDITHEC CORPORATION INFORMATION 53
6.6.2 CHAMEDITHEC DESCRIPTION AND BUSINESS OVERVIEW 54
6.6.3 CHAMEDITHEC MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022) 54
6.6.4 CHAMEDITHEC MESOTHERAPY PRODUCT PORTFOLIO 55
6.7 DONG KOOK LIFESCIENCE 55
6.7.1 DONG KOOK LIFESCIENCE CORPORATION INFORMATION 55
6.7.2 DONG KOOK LIFESCIENCE DESCRIPTION AND BUSINESS OVERVIEW 56
6.7.3 DONG KOOK LIFESCIENCE MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022) 56
6.7.4 DONG KOOK LIFESCIENCE MESOTHERAPY PRODUCT PORTFOLIO 57
6.8 HUONS 57
6.8.1 HUONS CORPORATION INFORMATION 57
6.8.2 HUONS DESCRIPTION AND BUSINESS OVERVIEW 58
6.8.3 HUONS MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022) 58
6.8.4 HUONS MESOTHERAPY PRODUCT PORTFOLIO 59
6.9 BLOOMAGEFREDA 59
6.9.1 BLOOMAGEFREDA CORPORATION INFORMATION 59
6.9.2 BLOOMAGEFREDA DESCRIPTION AND BUSINESS OVERVIEW 60
6.9.3 BLOOMAGEFREDA MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022) 60
6.9.4 BLOOMAGEFREDA MESOTHERAPY PRODUCT PORTFOLIO 60
6.10 SHANGHAI QISHENG 62
6.10.1 SHANGHAI QISHENG CORPORATION INFORMATION 62
6.10.2 SHANGHAI QISHENG DESCRIPTION AND BUSINESS OVERVIEW 62
6.10.3 SHANGHAI QISHENG MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022) 63
6.10.4 SHANGHAI QISHENG MESOTHERAPY PRODUCT PORTFOLIO 63
6.11 EVE CHARM 63
6.11.1 EVE CHARM CORPORATION INFORMATION 63
6.11.2 EVE CHARM DESCRIPTION AND BUSINESS OVERVIEW 64
6.11.3 EVE CHARM MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022) 64
6.11.4 EVE CHARM MESOTHERAPY PRODUCT PORTFOLIO 65
6.12 PAVAY 65
6.12.1 PAVAY CORPORATION INFORMATION 65
6.12.2 PAVAY DESCRIPTION AND BUSINESS OVERVIEW 66
6.12.3 PAVAY MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022) 66
6.12.4 PAVAY MESOTHERAPY PRODUCT PORTFOLIO 66
6.13 SUNMAX BIOTECH 67
6.13.1 SUNMAX BIOTECH CORPORATION INFORMATION 67
6.13.2 SUNMAX BIOTECH DESCRIPTION AND BUSINESS OVERVIEW 68
6.13.3 SUNMAX BIOTECH MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022) 68
6.13.4 SUNMAX BIOTECH MESOTHERAPY PRODUCT PORTFOLIO 68
6.14 IMEIK 69
6.14.1 IMEIK CORPORATION INFORMATION 69
6.14.2 IMEIK DESCRIPTION AND BUSINESS OVERVIEW 69
6.14.3 IMEIK MESOTHERAPY SALES, REVENUE AND GROSS MARGIN (2017-2022) 70
6.14.4 IMEIK MESOTHERAPY PRODUCT PORTFOLIO 70
7 MESOTHERAPY MANUFACTURING COST ANALYSIS 71
7.1 MESOTHERAPY KEY RAW MATERIALS ANALYSIS 71
7.1.1 KEY RAW MATERIALS 71
7.1.2 KEY SUPPLIERS OF RAW MATERIALS 71
7.2 PROPORTION OF MANUFACTURING COST STRUCTURE 72
7.3 MANUFACTURING PROCESS ANALYSIS OF MESOTHERAPY 73
7.4 MESOTHERAPY INDUSTRIAL CHAIN ANALYSIS 74
8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS 75
8.1 MARKETING CHANNEL 75
8.2 MESOTHERAPY DISTRIBUTORS LIST 76
8.3 MESOTHERAPY CUSTOMERS ANALYSIS 77
9 MESOTHERAPY MARKET DYNAMICS 78
9.1 MESOTHERAPY INDUSTRY TRENDS 78
9.2 MESOTHERAPY MARKET DRIVERS 78
9.3 MESOTHERAPY MARKET CHALLENGES 78
9.4 MESOTHERAPY MARKET RESTRAINTS 79
10 GLOBAL MARKET FORECAST 80
10.1 MESOTHERAPY MARKET ESTIMATES AND PROJECTIONS BY TYPE 80
10.1.1 GLOBAL FORECASTED SALES OF MESOTHERAPY BY TYPE (2023-2028) 80
10.1.2 GLOBAL FORECASTED REVENUE OF MESOTHERAPY BY TYPE (2023-2028) 80
10.2 MESOTHERAPY MARKET ESTIMATES AND PROJECTIONS BY APPLICATION 81
10.2.1 GLOBAL FORECASTED SALES OF MESOTHERAPY BY APPLICATION (2023-2028) 81
10.2.2 GLOBAL FORECASTED REVENUE OF MESOTHERAPY BY APPLICATION (2023-2028) 81
10.3 MESOTHERAPY MARKET ESTIMATES AND PROJECTIONS BY REGION 82
10.3.1 GLOBAL FORECASTED SALES OF MESOTHERAPY BY REGION (2023-2028) 82
10.3.2 GLOBAL FORECASTED REVENUE OF MESOTHERAPY BY REGION (2023-2028) 83
11 RESEARCH FINDINGS AND CONCLUSION 84
12 METHODOLOGY AND DATA SOURCE 85
12.1 METHODOLOGY/RESEARCH APPROACH 85
12.1.1 RESEARCH PROGRAMS/DESIGN 85
12.1.2 MARKET SIZE ESTIMATION 86
12.1.3 MARKET BREAKDOWN AND DATA TRIANGULATION 87
12.2 DATA SOURCE 88
12.2.1 SECONDARY SOURCES 88
12.2.2 PRIMARY SOURCES 89
12.3 AUTHOR LIST 92
12.4 DISCLAIMER 92

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

QYResearch社の
Fatal error: Uncaught TypeError: Cannot access offset of type string on string in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php:630 Stack trace: #0 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68d51da90169e8_18903235() #1 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #2 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #3 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(385): Smarty_Internal_Template->render() #4 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/f20300271f4eb0fb4a2cf788aaabb06be5646d19_0.file.frame-FULL.tpl.php(278): Smarty_Internal_Template->_subTemplateRender() #5 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68b0f61a4d9868_07068969() #6 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #7 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #8 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(238): Smarty_Internal_Template->render() #9 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(134): Smarty_Internal_TemplateBase->_execute() #10 /var/www/vhosts/dri.co.jp/httpdocs/auto/show_report.php(776): Smarty_Internal_TemplateBase->display() #11 {main} thrown in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php on line 630